What is a 24‑hour urine free normetanephrine test used to detect?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

What is a 24-Hour Urine Free Normetanephrine Test Used For?

A 24-hour urine free normetanephrine test is used to screen for pheochromocytoma and paraganglioma (PPGL)—rare catecholamine-secreting tumors of the adrenal glands and sympathetic nervous system—though it is no longer the preferred first-line test because plasma free metanephrines and urinary fractionated metanephrines offer superior diagnostic accuracy. 1

Primary Clinical Indication

  • Pheochromocytoma and paraganglioma detection: The test is ordered when a patient presents with hypertension accompanied by episodic headaches, palpitations, or sweating, or when an adrenal mass is incidentally discovered on imaging (approximately 5% of adrenal incidentalomas are pheochromocytomas). 1

  • Hereditary syndromes: It is also indicated in individuals with genetic predispositions such as SDH mutations, von Hippel-Lindau disease, MEN 2, and neurofibromatosis type 1. 1

Why Normetanephrine Specifically?

  • Normetanephrine is the O-methylated metabolite of norepinephrine and is produced continuously within chromaffin tumor cells by catecholamine O-methyltransferase, independent of episodic catecholamine release. 1

  • Continuous production makes metanephrines (including normetanephrine) more reliable markers than catecholamines themselves, which are released intermittently via exocytosis and lead to false-negative results in 16–26% of cases. 1

Diagnostic Performance and Limitations

  • Sensitivity: Urinary fractionated metanephrines (which include normetanephrine) achieve 97–100% sensitivity for detecting PPGL, far exceeding the 47–74% sensitivity of urinary catecholamines alone. 1

  • Specificity: Urinary fractionated metanephrines demonstrate 94–98% specificity. 1

  • Collection quality is critical: Incomplete 24-hour urine collections are a frequent source of diagnostic error; urinary creatinine must be measured to confirm collection completeness. 1

  • Renal impairment: Mild-to-moderate chronic kidney disease (eGFR ≥15 mL/min/1.73 m²) does not significantly affect urine normetanephrine measurements, but advanced renal impairment (eGFR <15) may lower results and require CKD-specific reference ranges or alternative testing. 2

Guideline Recommendations: Why This Test Is No Longer First-Line

  • The Endocrine Society strongly recommends against using urinary catecholamines as the initial biochemical test and instead advises urinary fractionated metanephrines (which include normetanephrine) or plasma free metanephrines as first-line options. 1

  • Plasma free metanephrines are preferred when proper supine collection (≥30 minutes recumbent before phlebotomy) can be performed, because they avoid collection-dependent errors inherent to 24-hour urine testing (patient compliance, storage, incomplete collection). 1

  • Urinary fractionated metanephrines should be used when supine plasma collection is not feasible—for example, when phlebotomy services routinely draw blood in the seated position, which markedly raises false-positive rates. 1

Common Pitfalls and How to Avoid Them

  • Incomplete urine collection: Always verify collection adequacy by measuring urinary creatinine; incomplete collections yield falsely low results. 1

  • Dietary and medication interference: Patients must avoid specific foods (avocados, bananas, cantaloupe, eggplant, pineapple, plum, tomato, hickory nuts, plantain, kiwi, dates, grapefruit, honeydew, walnut) and substances (coffee, alcohol, tobacco) for at least 48 hours before collection. 3

  • Drug interference: β-blockers, calcium channel blockers, loop diuretics, α-blockers, non-metformin antidiabetic drugs, and neuroleptics significantly elevate urinary normetanephrine; α-blockers also raise metanephrine, while antidepressants and glucocorticosteroids lower it. 4 Tricyclic antidepressants interfere with interpretation of both plasma and urinary metanephrine measurements. 1

  • Specimen contamination: Contamination with soap, bleach, or ammonia invalidates results; dilution by adding extra fluid lowers measured concentrations. 3

  • Inpatient testing: Hospitalized patients—especially those in intensive care—have markedly elevated normetanephrine levels due to physiological stress, producing substantial overlap with true pheochromocytoma; 98% specificity in ICU patients requires results more than fivefold above the upper reference limit, yet positive predictive value remains poor. 5

  • Reference interval issues: Traditional reference intervals derived from healthy volunteers are inappropriately low for the population being screened; age-stratified intervals derived from actual clinical screening data reduce false positives without compromising sensitivity. 6

Practical Testing Algorithm

  1. First-line test selection:

    • Order plasma free metanephrines if the patient can lie supine ≥30 minutes before phlebotomy and the laboratory uses LC-MS/MS or LC-electrochemical detection. 1
    • Order 24-hour urinary fractionated metanephrines (including normetanephrine) if supine plasma collection is impossible or if phlebotomy is routinely performed seated. 1

  2. Pre-collection preparation for urine testing:

    • Instruct the patient to avoid interfering foods and substances for 48 hours. 3
    • Review and document all medications; consider temporary discontinuation of interfering agents if clinically safe. 4
    • Provide clear instructions on proper collection technique to avoid contamination. 3

  3. Verify collection adequacy:

    • Measure urinary creatinine to confirm completeness. 1

  4. Interpret results in context:

    • If normetanephrine is markedly elevated (>4× upper limit of normal), proceed directly to imaging for tumor localization. 1
    • If borderline elevated, repeat testing under optimal conditions or perform a clonidine suppression test. 1
    • In hospitalized or ICU patients, interpret with extreme caution; consider deferring testing until the patient is stable and outpatient. 5

  5. Never rely on a normal result alone to exclude PPGL in high-risk patients (hereditary syndromes, adrenal incidentaloma); a normal urinary normetanephrine does not rule out disease. 1

Additional Clinical Context

  • Prognostic marker: Emerging evidence suggests that urine normetanephrine may predict all-cause mortality in patients with adrenal adenomas, independent of pheochromocytoma diagnosis, though this application is not yet guideline-endorsed. 7

  • Comparison with plasma testing: In a Mayo Clinic study, plasma free metanephrines had 97% sensitivity but only 85% specificity, whereas 24-hour urinary total metanephrines and catecholamines had 90% sensitivity but 98% specificity; urinary testing yields fewer false positives, making it preferred for low-risk patients, while plasma testing is preferred for high-risk patients with familial syndromes. 8

  • Seated plasma collection: If plasma metanephrines are drawn in the seated position (rather than supine), specificity drops markedly; one study found seated plasma testing had 96.4% sensitivity but only 75.6% specificity compared with 94.2% for urinary fractionated metanephrines. 9

References

1
Guideline

Plasma Catecholamine Measurement in the Diagnosis of Pheochromocytoma and Paraganglioma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

3
Guideline

Guidelines for Accurate Urine Dopamine Measurement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the significance of a 24‑hour urinary normetanephrine of 583 µg and urinary metanephrine of 112 µg?
Is a 24‑hour urinary metanephrine of 34 µg and normetanephrine of 84 µg clinically significant?
What does a positive 24‑hour urine metanephrines result indicate and how should it be evaluated and managed?
What is the normal reference range for normetanephrine in plasma (free) and 24‑hour urine?
How long does it take for random urine metanephrines results to be returned?
How should acute balanitis be treated, including hygiene measures and appropriate topical and oral therapies?
Can exposure to Agent Orange cause gastroesophageal reflux disease (GERD)?
Which rheumatologic disorders can cause vasospasm and/or cellulitis-like skin inflammation?
What is appropriate treatment for sinusitis in a patient with fatty liver disease, controlled pulmonary hypertension, penicillin allergy, and a normal chest X‑ray?
What are the recommended management strategies for treatment‑resistant bipolar II depression?
What is the appropriate evaluation and management of unintentional weight loss in a patient with chronic obstructive pulmonary disease (COPD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.